- Home
- IPHA vs SRG Comparison
IPHA vs SRG Comparison
Compare IPHA & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- SRG
- Stock Information
- Founded
- IPHA 1999
- SRG 2014
- Country
- IPHA France
- SRG United States
- Employees
- IPHA N/A
- SRG N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- SRG Real Estate Investment Trusts
- Sector
- IPHA Health Care
- SRG Real Estate
- Exchange
- IPHA Nasdaq
- SRG Nasdaq
- Market Cap
- IPHA 160.1M
- SRG 163.3M
- IPO Year
- IPHA 2019
- SRG 2015
- Fundamental
- Price
- IPHA $1.74
- SRG $3.05
- Analyst Decision
- IPHA Strong Buy
- SRG
- Analyst Count
- IPHA 1
- SRG 0
- Target Price
- IPHA $11.00
- SRG N/A
- AVG Volume (30 Days)
- IPHA 11.2K
- SRG 92.7K
- Earning Date
- IPHA 09-11-2025
- SRG 08-13-2025
- Dividend Yield
- IPHA N/A
- SRG N/A
- EPS Growth
- IPHA N/A
- SRG N/A
- EPS
- IPHA N/A
- SRG N/A
- Revenue
- IPHA $20,831,349.00
- SRG N/A
- Revenue This Year
- IPHA $209.83
- SRG N/A
- Revenue Next Year
- IPHA $83.15
- SRG N/A
- P/E Ratio
- IPHA N/A
- SRG N/A
- Revenue Growth
- IPHA N/A
- SRG N/A
- 52 Week Low
- IPHA $1.29
- SRG $2.43
- 52 Week High
- IPHA $3.51
- SRG $5.52
- Technical
- Relative Strength Index (RSI)
- IPHA 42.70
- SRG 58.29
- Support Level
- IPHA $1.71
- SRG $2.94
- Resistance Level
- IPHA $1.90
- SRG $3.18
- Average True Range (ATR)
- IPHA 0.08
- SRG 0.11
- MACD
- IPHA 0.00
- SRG 0.01
- Stochastic Oscillator
- IPHA 47.62
- SRG 78.13
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.